Erlotinib Hydrochloride
- Product NDC
- 42292-053
- 11-digit product format
- 422920053
- Labeler code
- 42292
- Product ID
- 42292-053_b4dc994e-d507-2fc0-e053-2a95a90ae131
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- erlotinib hydrochloride
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Mylan Institutional Inc.
- Application
- ANDA091002
- Marketing category
- ANDA
- Marketing start
- 2019-05-28
- Marketing end
- 2021-01-31
- Substance
- ERLOTINIB
- Active strength
- 150 mg/1
- Pharmacologic classes
- Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record